EUCTR2009-014769-16-IT进行中(未招募)不适用
REWORD-HF REverse WOrsening Renal function in Decompensated Heart Failure Impact of different therapeutic approaches in patients with cardiorenal syndrome in the setting of acute decompensated congestive heart failure (ADCHF) - REWORD-HF
AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA` GRANDA (A.O. DI RILIEVO NAZIONALE)0 个研究点开始时间: 2009年11月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Informed consent On admission - Age 18-80 years - NYHA class III IV - Signs of pulmonary (pulmonary rales, and interstitial oedema or pleural effusion on chest Xray) and/or systemic congestion (pitting ankle oedema and enlarged liver or ascites and neck vein distension ≥ 7 cm) and weight gain ≥ 2 kg during the previous week - Glomerular filtration rate ≥ 30 ml/min - BNP increased >400 pg/ml (diagnostic cut-off for ADCHF), as confirmatory diagnostic test28 24 hours after admission (randomization) - Persistents signs of pulmonary (pulmonary rales, interstitial oedema or pleural effusion on chest Xray) and/or systemic congestion (ankle oedema, enlarged liver or ascites, neck vein distension ≥ 7 cm) - Serum creatinine or urine output criteria indicative of modified RIFLE (AKI: risk) class at least 1 (increase x 1.5 in serum creatinine or decrease > 25% in GFR or urine output < 0.5 ml/Kg/h for more than 6 hours) 29-30 during diuretic infusion
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Chronic kidney disease stage 4-5 (GFR < 30 ml/min) - Acute coronary syndromes - Systolic blood pressure <90 mm Hg/need for intravenous inotropes - Hematocrit > 45% - Unattainable venous access - Contraindications to anticoagulation by heparin - Systemic infection - Heart transplant
研究者
相似试验
招募中
不适用
Consideration the changes of renal function for renal cell carcinoma patients, administered the molecular target drugs: axitinib, sunitinib and sorafenibRenal cell carcinomaJPRN-UMIN000019393Dokkyo Medical University, Department of Urology30
进行中(未招募)
1 期
Evaluation of the impact of renal function on the pharmacokinetics of hydroxyurea (Siklos®) in patients with sickle cell disease with normal renal function, with hyperfiltration, or with renal failure. DARH studySiklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in adults, adolescents and children older than 2 years suffering from symptomatic sickle cell syndrome.MedDRA version: 17.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004851EUCTR2014-005033-31-FRAddmedica S.A.S
招募中
不适用
Examination of the effects on renal function and prognosis of various diuretics for liver cirrhosisiver cirrhosisJPRN-UMIN000040179Hokkaido University400
已完成
不适用
rinary neutrophil gelatinase-associated lipocalin(NGAL) excretion and Renal Functions in Mild Maternal HydronephrosisMild Maternal Hydronephrosis in PregnancyRenal and Urogenital - Kidney diseaseReproductive Health and Childbirth - Fetal medicine and complications of pregnancyACTRN12614000455662Emre Goksan Pabuccu86
已完成
不适用
The effect of Renal Denervation on Renal Flow in Humanshigh blood pressureintrarenal flow10057166NL-OMON39747niversitair Medisch Centrum Utrecht20
